eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2018
vol. 14
 
Share:
Share:
more
 
 
abstract:
Clinical research

Utility and safety of three-dimensional contrast low-dose dobutamine echocardiography in the evaluation of myocardial viability early after an acute myocardial infarction

Piotr Scisło, Janusz Kochanowski, Łukasz Kołtowski, Grzegorz Opolski

Arch Med Sci 2018; 14, 3: 488–492
Online publish date: 2016/03/17
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The aim of the study was to determine the utility and safety of three-dimensional contrast low-dose dobutamine echocardiography (3DCLDDE) in the evaluation of myocardial viability early after ST-elevation myocardial infarction (STEMI).

Material and methods
We prospectively evaluated a group of 100 consecutive patients. Myocardial viability was assessed using dobutamine echocardiography in 76 patients with segmental wall motion abnormalities, including 37 patients evaluated using 3DCLDDE and 39 patients evaluated using a standard low-dose dobutamine echocardiography protocol (LDDE), alternately.

Results
Single ventricular ectopic beats were observed during the test in 1 (2.5%, 1, p = 1) patient in the 3DCLDDE group, while pain (1, p = 1) dyspnea (1, p = 1), single ventricular beats (2, p = 1), and complex ventricular arrhythmia (2, p = 0.49) were noted in 4 (10%) patients in the LDDE group. Five-year survival was 89% in the 3DCLDDE group and 87% in the LDDE group.

Conclusions
3DCLDDE and LDDE are equally safe and useful in patients after STEMI.

keywords:

three-dimensional contrast dobutamine stress echocardiography

references:
Steg PG, James SK, Atar D, et al.; ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012; 33: 2569-619.
Bax JJ, Poldermans D, Visser FC, et al. Delayed recovery of hibernating myocardium after surgical revascularization: implications for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability. J Nucl Cardiol 1999; 6: 685-7.
Ay T, Pasquet A, Robert A, et al. Usefulness of low-dose dobutamine echocardiography for selection of patients with severely depressed left ventricular function for coronary bypass grafting. Am J Cardiol 2002; 90: 323-5.
Lang RM, Badano LP, Tsang W, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging 2012; 13: 1-46.
Pulerwitz T, Hirata K, Abe Y, et al. Feasibility of using a real-time 3-dimensional technique for contrast dobutamine stress echocardiography. J Am Soc Echocardiogr 2006; 19: 540-5.
Lipiec P, Wejner-Mik P, Krzemińska-Pakuła M, et al. Accelerated stress real-time myocardial contrast echocardiography for the detection of coronary artery disease: comparison with 99mtc single photon emission computed tomography. J Am Soc Echocardiogr 2008; 21: 941-7.
Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging 2009; 2: 412-24.
Salustri A, Elhendy A, Garyfallydis P, et al. Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 1994; 74: 853-6.
Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Lancet 1994; 344: 1190-2.
Wejner-Mik P, Lipiec P, Kasprzak JD. Long-term prognostic value of dipyridamole stress myocardial contrast echocardiography. Eur J Echocardiogr 2011; 12: 762-6.
Huang WC, Chiou KR, Liu CP, et al. Comparison of real-time contrast echocardiography and low-dose dobutamine stress echocardiography in predicting the left ventricular functional recovery in patients after acute myocardial infarction under different therapeutic intervention. Int J Cardiol 2005; 104: 81-91.
Hillis GS, Mulvagh SL, Pellikka PA, et al. Comparison of intravenous myocardial contrast echocardiography and low-dose dobutamine echocardiography for predicting left ventricular functional recovery following acute myocardial infarction. Am J Cardiol 2003; 92: 504-8.
Wei K, Mulvagh SL, Carson L, et al. The safety of definity and optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr 2008; 21: 1202-6.
Senior R, Moreo A, Gaibazzi N, et al. Comparison of sulfur hexafluoride microbubble (sonovue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European Multicenter Study. J Am Coll Cardiol 2013; 62: 1353-61.
Porter TR, Abdelmoneim S, Belcik JT, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. J Am Soc Echocardiogr 2014; 27: 797-810.
Tsutsui JM, Elhendy A, Xie F, O’Leary EL, McGrain AC, Porter TR. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 2005; 45: 1235-42.
Timperley J, Mitchell ARJ, Thibault H, Mirza IH, Becher H. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr 2005; 18: 163-7.
Timperley J, Becher H. Safety of dobutamine contrast stress echocardiography. J Am Coll Cardiol 2005; 46: 1963.
Gaibazzi N, Silva L, Reverberi C. Safety and positive predictive value of high-dose dipyridamole stress-echocardiography with or without contrast flash-replenishment perfusion imaging in patients with suspected or known coronary artery disease. Int J Cardiol 2012; 154: 382-3.
Gaibazzi N, Marziliano N, Porter TR, et al. Assessment of DNA damage associated with standard or contrast diagnostic echocardiography. Int J Cardiol 2015; 180: 96-9.
Bernheim AM, Kittipovanonth M, Takahashi PY, Gharacholou SM, Scott CG, Pellikka PA. Does the prognostic value of dobutamine stress echocardiography differ among different age groups? Am Heart J 2011; 161: 740-5.
Abram S, Arruda-Olson AM, Scott CG, et al. Typical blood pressure response during dobutamine stress echocardiography of patients without known cardiovascular disease who have normal stress echocardiograms. Eur Heart J Cardiovasc Imaging 2015 Jul 22. pii: jev165. [Epub ahead of print].
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe